BIT’s Annual World Congress of Endobolism-2011 was held successfully in Xiamen International Conference & Exhibition Center, Xiamen, China during January 25-27. The conference was supported by CCPIT OF DaLian. This year’s congress has obtained highly focus and extensive attentions throughout the world. Honorable leaders and distinguished guests worldwide have come all the way to attend this congress.
The congress includes night symposiums, 32 sessions. As keynote speakers, Dr. G. Alexander Fleming, President and CEO, Kinexum LLC, USA; Dr. James Y. Yang, Professor, Department of Biomedical Sciences, School of Life Sciences, Xiamen University, China; Dr. Michael R. Hanley, Chief Scientific Officer, Amylin Pharmaceuticals, Inc., USA and Dr. Ruian Xu, Professor and Director, Engineering Research Center of Molecular Medicine, Ministry of Education & Institute of Molecular Medicine, Huaqiao University, China, gave attendees wonderful speeches at Keynote Forum. Over nearly 200 renowned professors, laboratory principals, project leaders and representatives of well-known enterprises attended the ceremony.
This innovative conference brings together from around the world leading scientists, researchers and clinicians from the fields of diabetes, endocrinology as well as metabolism. The dual aims are to promote information exchange and linkages between specialists from different areas, and to foster interchange between those with different scientific emphasizes in studying endocrinology and metabolism. Endocrinology diseases have been receiving rising recognition globally and one of the challenges facing the practice of endocrinology in China and other parts of the world is the diabetes epidemic and its clinical treatment. During the conference, a number of distinguished speakers join us discussing the latest advances in the field of diabetes or endocrinology. At the same time, WCE-2011 offers an exciting program covering a wide array of topics in endocrinology and metabolism presented through a keynote forum, interactive sessions, state of the art lectures, extended talks, poster sessions, and exhibition.
Most participants gave a high appraisal to WCE-2011. According to the investigations after the conference, over 90% participants expressed that they would like to attend WCE-2012. Depending on the warmly support and good suggestions from all of the participants, we are confident in organizing WCE-2012 which would be better and more successful than WCE-2011
Yours sincerely
Organizing Committee of World Congress of Endobolism- 2011
Acquire an overview of new technologies and the research being done by other leaders in the fields of endocrinology and metabolism during the keynote forum and subsequent sessions.
Technology workshops that highlight new advances
Opportunity to introduce your own techniques and research to colleagues at poster sessions
Exhibition and industry workshops daily
Networking opportunities to foster friendships and promote collaborations
As an exhibitor at EndoBolism-2011 you can present your products as service to a group of motivated and well-informed professionals from around the world. You can communicate directly with experts in the field who need your services and have a special interest in your products. The delegates attending EndoBolism-2011 are mainly senior scientists directly responsible for the development of research programs worldwide, specifically purchasing laboratory diagnostic and medical equipment.
Advantages for Exhibitors
The exhibition will be visited by participants of the conference from China and many other countries who are your target customers.
Exhibits give you the opportunity to present more details about your products and services to those who are interested, and allow you to have longer discussions than during session discussions.
Dr. Jan-Ake Gustafsson, Professor, Department of Biosciences & Nutrition, University of Houston, USA
Dr. G. Alexander Fleming, President and CEO, Kinexum LLC, USA
Dr. Michael R. Hanley, Chief Scientific Officer, Amylin Pharmaceuticals, Inc., USA
Dr. Naima Moustaid-Moussa, Professor, Department of Animal Science, Co-Director, UT Obesity Research Center, The University of Tennessee, USA
Dr. Xiao-kun Zhang, Professor and Dean, Institute for Biomedical Research, Xiamen University, China; Sanford-Burnham Medical Research Institute, USA
Dr. John A. Cidlowski, Head of the Molecular Endocrinology Group within the LST, National Institutes of Environmental Health Sciences, USA
Dr. Erin Pias Hines, Biologist, US Environmental Protection Agency, USA
Dr. Jean-Patrice Baillargeon, Director of Endocrinology Metabolism, University of Sherbrooke, Canada
Dr. Xavier Bonnefont, Professor, The Institute of Functional Genomics, CNRS, France
Dr. Nader Rahnama, Professor of Sport Medicine, Florida State University, USA
Dr. Christopher Wilcox, Director, Center for Hypertension, Kidney and Vascular Health, Georgetown University, USA
Dr. Eugenio Cersosimo, Medical Director of Clinical Research, Texas Diabetes Institute, University of Texas, USA
Dr. Ming Wang, Director of Metabolism Group, Amgen Inc., USA
Dr. Enrico Carmina, Executive Director of Androgen Excess and PCOS Society, Head of Endocrine Unit, University of Palermo, Italy
Dr. Alan Maisel, Principal Investigator, UCSD, San Diego VA Hospital, USA
Dr. Serge CARREAU, Director Research CNRS, Université de Caen Basse-Normandie, France
Dr. William B Inabnet, Director of Surgical Sciences, Metabolic Institute, Mount Sinai Medical Center, USA
Dr. Dace L.Trence, Director, Diabetes Care Center, University of Washington Medical Center, USA
Dr. Bradford Therrell, Professor, The Department of Pediatrics at the University of Texas Health Science Center at San Antonio, USA
Dr. Hadas Stiebel-Kalish, Chief, Neuro-Ophthalmology, Rabin Medical Center, Israel
Dr. Zhaohui Ni, Director, Renal Division, Renji Hospital, Shanghai Jiaotong University School of Medicine, China
Dr. Gwen V. Childs, Professor and Chair, Department of Neurobiology and Developmental Sciences, College of Medicine, University of Arkansas for Medical Sciences, USA
Dr. Matthias Bureik, CEO, Chemist, Co-Founder, PomBioTech, Germany
Dr. Russel J. Reiter, Professor, Department of Cellular and Structural Biology, University of Texas Health Science Center, USA
